Form 8-K

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TcZbIPvm9jsMeZrEMAys7NUCKpaXzW7+MytwKJj5jHSwR9DGquF3w36iJgSVbevt qurQH0jD7CTN5yo7G4sK9Q== 0001193125-10-052408.txt : 20100310 0001193125-10-052408.hdr.sgml : 20100310 20100310141810 ACCESSION NUMBER: 0001193125-10-052408 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100309 ITEM INFORMATION: Other Events FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VARIAN INC CENTRAL INDEX KEY: 0001079028 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770501995 STATE OF INCORPORATION: DE FISCAL YEAR END: 1003 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-25393 FILM NUMBER: 10670013 BUSINESS ADDRESS: STREET 1: 3120 HANSEN WAY CITY: PALO ALTO STATE: CA ZIP: 94304-1030 BUSINESS PHONE: 650-213-8000 MAIL ADDRESS: STREET 1: 3120 HANSEN WAY CITY: PALO ALTO STATE: CA ZIP: 94304 8-K 1 d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 9, 2010

Varian, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation)

000-25393

(Commission File Number)

77-0501995

(IRS Employer Identification No.)


3120 Hansen Way, Palo Alto, California		94304-1030
(Address of principal executive offices)		(Zip Code)

(650) 213-8000

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01

Other Events

Agilent Technologies, Inc. (“Agilent”) and Bruker Corporation (“Bruker”) announced on March 9, 2010 that they entered into a definitive asset purchase agreement pursuant to which Bruker will acquire certain product lines of Varian, Inc. As previously disclosed, Agilent committed to divest those product lines in connection with obtaining regulatory approval for Agilent’s pending acquisition of Varian.

The product lines to be acquired by Bruker are:

•

Varian’s inductively coupled plasma mass spectrometry (ICP-MS) instruments business;

•

Varian’s laboratory gas chromatography (Lab GC) instruments business; and

•

Varian’s gas chromatography triple-quadrupole mass spectrometry (GC-MS QQQ) instruments business.

Agilent and Bruker announced that their transaction is subject to customary closing conditions and regulatory approvals, and is expected to close shortly after Agilent completes its acquisition of Varian (which Agilent anticipates will occur by April 30, 2010, following regulatory approvals).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


VARIAN, INC. (Registrant)

By		/s/ A.W. HOMAN
		A.W. Homan Senior Vice President, General Counsel and Secretary

Date: March 10, 2010

-----END PRIVACY-ENHANCED MESSAGE-----